2022
DOI: 10.1016/j.phymed.2022.154166
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Qingfei Paidu decoction combined with Western medicine treatments for COVID-19: A systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
13
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 42 publications
1
13
0
Order By: Relevance
“…In this study, we concluded that QFPDD might help improve the clinical symptoms of COVID-19 patients with other respiratory diseases; no serious adverse events related to QFPDD were observed, which was in line with previous studies ( Wang J. et al, 2021 ; Wang Q. et al, 2021 ; Chen et al, 2021 ; Zhang et al, 2021 ; Zhang et al, 2022 ). The results of this study may provide a reference for clinicians to use QFPDD treatment.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…In this study, we concluded that QFPDD might help improve the clinical symptoms of COVID-19 patients with other respiratory diseases; no serious adverse events related to QFPDD were observed, which was in line with previous studies ( Wang J. et al, 2021 ; Wang Q. et al, 2021 ; Chen et al, 2021 ; Zhang et al, 2021 ; Zhang et al, 2022 ). The results of this study may provide a reference for clinicians to use QFPDD treatment.…”
Section: Discussionsupporting
confidence: 91%
“…In addition, it also had inspiring effects on the treatment of COVID-19, and early treatment with Qingfei Paidu decoction (QFPDD) was associated with favorable outcomes ( Shi et al, 2020 ; Ma et al, 2020 ). Moreover, two systematic reviews and meta-analyses demonstrated the effectiveness and safety of QFPDD in treating COVID-19 patients ( Wang J. et al, 2021 ; Zhang et al, 2022 ). Since the sixth version of the national guideline Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia has been issued, QFPDD has been recommended as a general formula for the treatment of all COVID-19 patients including mild, moderate, severe, and critically ill cases.…”
Section: Introductionmentioning
confidence: 99%
“… 23 Based on TCM theory, three Chinese patent medicines (including Lianhua Qingwen Capsule, Jinhua Qinggan Granules, and Xuebijing Injection) as well as three herbal prescriptions (including Xuanfeibaidu Recipe, Huashi Paidu Recipe, and Qingfei Paidu Decoction) have been identified to prevent the transmission of SARS-CoV-2 and to treat COVID-19. 8 So far, more and more clinical evidences have suggested the inspiring effectiveness and safety of these prescriptions of Chinese herbs such as Qingfei Paidu Decoction, 21 , 22 Lianhua Qingwen Capsule 24 , 25 and Huashi Paidu Recipe 26 in controlling COVID-19. Moreover, the potential anti-SARS-CoV-2 characteristics of some single Chinese herbs particularly attracted increasing interest of scientists.…”
Section: Introductionmentioning
confidence: 99%
“…16,20 To control the current COVID-19 pandemic in China, the Chinese government has implemented multiple effective strategies, among which the application of traditional Chinese herbal formulas has been officially recommended in the national Guideline of Diagnosis and Treatment Plan for COVID-19 as an important complement to conventional treatment for different phases of COVID-19, including mild, moderate, severe, even critically ill patients. 7,9,[21][22][23] The Chinese state media and medical experts also strongly promoted the idea of using traditional Chinese herbal medicine as an integral part of the COVID-19 control plan. 23 Based on TCM theory, three Chinese patent medicines (including Lianhua Qingwen Capsule, Jinhua Qinggan Granules, and Xuebijing Injection) as well as three herbal prescriptions (including Xuanfeibaidu Recipe, Huashi Paidu Recipe, and Qingfei Paidu Decoction) have been identified to prevent the transmission of SARS-CoV-2 and to treat COVID-19.…”
Section: Introductionmentioning
confidence: 99%
“…Lianhua Qingwen capsules, supplied during the COVID-19 pandemic in Shanghai in 2022, shared the major ingredients of Shuang and Lian, while Qingfei Paidu decoction shared the major ingredient of Huang. 49, 50 Moreover, the involved ingredients, such as Atractylodes macrocephala Koidz, Belamcanda chinensis (L.) Redouté, and Citrus reticulata Blanco, contained similar components as those found in Shuanghuanglian.…”
Section: Similarity In the Compounds And Ingredientsmentioning
confidence: 93%